GV led a $58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases.
from RSS Feeds : RSS Feed - NDTV Gadgets360.com http://bit.ly/2DTO11A
Alphabet's GV Leads Funding in Gene Editing Company Verve Therapeutics
Photography
May 07, 2019
Reactions
You may like these posts
Author Details
Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat.
Search This Blog
Recent News
Archive
- December127
- November642
- October667
- September639
- August713
- July713
- June690
- May716
- April687
- March713
- February644
- January719
- December707
- November695
- October628
- September692
- August719
- July705
- June690
- May713
- April690
- March715
- February665
- January712
- December712
- November690
- October713
- September690
- August717
- July709
- June693
- May2927
- April2833
- March2914
- February2660
- January2888
- December2634
- November503
- March7
Featured
Post Top Ad
Post Top Ad
Post Top Ad
Recent
Comment
Sports
Slider
Technology
Extra Ads
Breaking
Pages
Recent Posts
3/recent/post-list
Categories
Tags
Recent in Recipes
3/Food/post-list
Menu Footer Widget
Designed with by Way2Themes | Distributed by Blogger Themes
0 Comments